{"title":"间充质干细胞来源的细胞外囊泡:一种有希望的COVID-19治疗方法?","authors":"","doi":"10.33140/jcei.06.06.05","DOIUrl":null,"url":null,"abstract":"Coronavirus disease 2019 (COVID-19) is a pandemic viral disease caused by severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2). Originated in Wuhan, China in December 2019, COVID-19 soon spread all around the world [1]. As per the WHO, till 4th August 2021, Globally, 200,174,883 confirmed cases of COVID-19, including 4,255,892 deaths and 3,984,596,440 vaccine doses have been administered [2].","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"25 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mesenchymal stem cells-derived Extracellular Vesicles: A Promising COVID-19 Therapy?”\",\"authors\":\"\",\"doi\":\"10.33140/jcei.06.06.05\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Coronavirus disease 2019 (COVID-19) is a pandemic viral disease caused by severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2). Originated in Wuhan, China in December 2019, COVID-19 soon spread all around the world [1]. As per the WHO, till 4th August 2021, Globally, 200,174,883 confirmed cases of COVID-19, including 4,255,892 deaths and 3,984,596,440 vaccine doses have been administered [2].\",\"PeriodicalId\":73657,\"journal\":{\"name\":\"Journal of clinical & experimental immunology\",\"volume\":\"25 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical & experimental immunology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33140/jcei.06.06.05\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical & experimental immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33140/jcei.06.06.05","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Mesenchymal stem cells-derived Extracellular Vesicles: A Promising COVID-19 Therapy?”
Coronavirus disease 2019 (COVID-19) is a pandemic viral disease caused by severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2). Originated in Wuhan, China in December 2019, COVID-19 soon spread all around the world [1]. As per the WHO, till 4th August 2021, Globally, 200,174,883 confirmed cases of COVID-19, including 4,255,892 deaths and 3,984,596,440 vaccine doses have been administered [2].
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
